• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖皮质激素对髓系白血病细胞的分化诱导——体内外分化诱导作用]

[Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].

作者信息

Nakamaki T, Sakashita A, Sano M, Hino K, Suzuki K, Tomoyasu S, Tsuruoka N

出版信息

Rinsho Ketsueki. 1989 Feb;30(2):149-57.

PMID:2746870
Abstract

The effects of glucocorticoid on the differentiation of myeloid leukemia cells were examined. Dexamethasone at 10(-6)M or 10(-7)M revealed marked effects not only on leukemic blasts' survival but also on its' differentiation in vitro. In 10 of 17 cases of myeloid leukemia, the obvious morphological and functional differentiation induction effects were observed in vitro. The direction of differentiation were differed in leukemia cell lineage and in cases. Granulocytic differentiation in M2 cells, mono-macrophage differentiation in M5 cells and either granulocytic or monocytic differentiation in M4 cells were induced. A AML (M2), it's leukemia cells were induced into granulocytic pathway by dexamethasone in vitro, was treated with prednisolone (40 mg per day).Ara-C (15 mg per day). The increase in peripheral leukocyte count and the decrease in immature cells were observed simultaneously. The peripheral leukocytes mainly consisted of intermediate forms of granulocytes and Pelger-Huët like neutrophils probably originated from leukemia cells. After that course, abnormal clone was eliminated from bone marrow. A AMoL, it's leukemia cells were induced into macrophage like cells completely by dexamethasone in vitro, was treated with prednisolone (30 mg per day) and complete remission was obtained without passing through a hematological nadir. It is indicated that anti-tumor effects of glucocorticoid on myeloid leukemia cells are closely related to it's differentiation inducing effect and glucocorticoid can be used as the drug intending for the differentiation induction therapy of acute myeloid leukemia.

摘要

研究了糖皮质激素对髓系白血病细胞分化的影响。10(-6)M或10(-7)M的地塞米松不仅对白血病原始细胞的存活有显著影响,而且对其体外分化也有显著影响。在17例髓系白血病患者中的10例中,体外观察到明显的形态学和功能分化诱导作用。白血病细胞系别和病例之间的分化方向不同。诱导M2细胞向粒细胞分化、M5细胞向单核-巨噬细胞分化以及M4细胞向粒细胞或单核细胞分化。1例急性髓系白血病(M2),其白血病细胞在体外被地塞米松诱导进入粒细胞途径,接受泼尼松龙(每天40mg)和阿糖胞苷(每天15mg)治疗。同时观察到外周血白细胞计数增加和未成熟细胞减少。外周血白细胞主要由粒细胞的中间形式和可能起源于白血病细胞的Pelger-Huët样中性粒细胞组成。经过该疗程后,骨髓中异常克隆被清除。1例急性单核细胞白血病,其白血病细胞在体外被地塞米松完全诱导为巨噬样细胞,接受泼尼松龙(每天30mg)治疗,未经历血液学最低点就获得了完全缓解。表明糖皮质激素对髓系白血病细胞的抗肿瘤作用与其分化诱导作用密切相关,糖皮质激素可作为急性髓系白血病分化诱导治疗的药物。

相似文献

1
[Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].[糖皮质激素对髓系白血病细胞的分化诱导——体内外分化诱导作用]
Rinsho Ketsueki. 1989 Feb;30(2):149-57.
2
The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.联合治疗在伴有中枢神经系统受累的成人急性髓系白血病中的价值。
Haematologica. 1997 Sep-Oct;82(5):577-80.
3
Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.通过对白血病干细胞进行体外药敏试验预测急性白血病的化疗反应
Cancer Res. 1984 Oct;44(10):4648-52.
4
The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.类固醇对髓系白血病细胞的作用:短疗程大剂量甲泼尼龙治疗在诱导分化、凋亡及刺激骨髓生成方面的潜力。
Leuk Res. 2006 Jan;30(1):60-8. doi: 10.1016/j.leukres.2005.05.015. Epub 2005 Jun 24.
5
[Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].[成人急性髓系白血病的缓解诱导治疗。两个连续方案的8年经验]
Med Clin (Barc). 1989 Apr 29;92(16):601-4.
6
Differentiation of myeloid cells in liquid culture: 2. Acute myelocytic leukemia cells.液体培养中髓系细胞的分化:2. 急性髓细胞白血病细胞。
Cell Biochem Funct. 1987 Jul;5(3):157-66. doi: 10.1002/cbf.290050302.
7
Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.急性髓系白血病患者骨髓中血管内皮生长因子(VEGF)的免疫组化检测。VEGF表达与FAB分型之间的相关性。
Am J Clin Pathol. 2003 May;119(5):663-71. doi: 10.1309/331Q-X7AX-KWFJ-FKXM.
8
Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.原发性耐药急性髓系白血病采用定时序贯化疗挽救治疗:预后因素分析
Ann Hematol. 2003 Nov;82(11):684-90. doi: 10.1007/s00277-003-0730-1. Epub 2003 Aug 19.
9
Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.白细胞介素3体内给药对急性髓系白血病增殖、分化及化疗敏感性的影响
Clin Cancer Res. 1995 Mar;1(3):295-303.
10
Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.柔红霉素、阿糖胞苷和氟达拉滨(DAF)用于复发或难治性急性髓系白血病的缓解诱导。安全性、耐受性及早期结果评估——波兰成人白血病组(PALG)的初步研究
Ann Hematol. 2008 May;87(5):361-7. doi: 10.1007/s00277-007-0421-4. Epub 2007 Dec 12.